We are proud to announce that AGILeBiotics has been awarded the Intellectual Property Voucher by the Netherlands Antibiotic Development Platform (NADP). The total amount of €5.000 will be allocated to secure AGILeBiotics’ IP position. In this regard, a patent application, which covers the company’s drug pipeline, will be drafted and filed in collaboration with the law firm Dompatent von Kreisler.

About NADP: The Netherlands Antibiotic Development Platform facilitates the collaboration between public and private organizations, to enhance the development of new antibiotics and alternative therapies for infectious diseases in humans and animals. An important objective of the NADP is to increase the productivity of research and development for new antibiotics and alternatives. In order to promote the accelerated development of promising ‘leads’, the NADP has developed a financing instrument specifically for this purpose: the NADP Vouchers. These Vouchers can be used in various phases of the drug development process to gain advice and intensive supervision of research projects from independent consultants or contract research organizations that have specific knowledge and expertise pertinent to the pharmaceutical development process and clinical applications. The options vary from lead identification and optimization, patent applications, and market analysis to pre-clinical drug development.